You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

GOSERELIN ACETATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for goserelin acetate and what is the scope of patent protection?

Goserelin acetate is the generic ingredient in one branded drug marketed by Tersera and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for goserelin acetate. One supplier is listed for this compound.

Summary for GOSERELIN ACETATE
US Patents:0
Tradenames:1
Applicants:1
NDAs:2
Drug Master File Entries: 4
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 49
Clinical Trials: 122
Patent Applications: 7,042
What excipients (inactive ingredients) are in GOSERELIN ACETATE?GOSERELIN ACETATE excipients list
DailyMed Link:GOSERELIN ACETATE at DailyMed
Recent Clinical Trials for GOSERELIN ACETATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sohag UniversityPhase 1
Gangnam Severance HospitalPhase 2
Seoul National UniversityPhase 2

See all GOSERELIN ACETATE clinical trials

Pharmacology for GOSERELIN ACETATE
Medical Subject Heading (MeSH) Categories for GOSERELIN ACETATE

US Patents and Regulatory Information for GOSERELIN ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for GOSERELIN ACETATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 ⤷  Sign Up ⤷  Sign Up
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 ⤷  Sign Up ⤷  Sign Up
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 ⤷  Sign Up ⤷  Sign Up
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 ⤷  Sign Up ⤷  Sign Up
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 ⤷  Sign Up ⤷  Sign Up
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 020578-001 Jan 11, 1996 ⤷  Sign Up ⤷  Sign Up
Tersera ZOLADEX goserelin acetate IMPLANT;IMPLANTATION 019726-001 Dec 29, 1989 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.